导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 21.34% | 35/354 |
| 近一周 | -3.75% | 279/356 |
| 近一月 | -0.30% | 87/362 |
| 近一季 | 15.91% | 46/362 |
| 近半年 | 24.15% | 17/358 |
| 近一年 | 53.69% | 8/349 |
| 近两年 | 41.86% | 86/314 |
| 近三年 | 77.57% | 22/244 |
| 成立以来 | 68.45% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.10% 44/360 |
20.38% 93/366 |
- - |
- - |
| 2025 | 29.50% 34/358 |
-9.81% 312/340 |
1.66% 226/348 |
18.38% 104/354 |
19.31% 4/358 |
| 2024 | 1.30% 221/329 |
5.85% 123/280 |
-1.91% 215/310 |
4.21% 180/318 |
-6.38% 249/329 |
| 2023 | 8.49% 92/275 |
-9.12% 188/205 |
14.21% 44/230 |
-11.44% 226/262 |
18.04% 3/276 |
| 2022 | -18.60% 83/201 |
-18.96% 124/153 |
-12.51% 106/164 |
12.28% 3/189 |
2.25% 148/202 |
| 2021 | -21.34% 85/150 |
-2.30% 260/312 |
-1.93% 276/328 |
-6.68% 193/358 |
-12.04% 136/151 |
| 2020 | 32.56% 22/103 |
-16.96% 199/280 |
40.53% 9/295 |
-4.63% 262/299 |
19.12% 25/305 |
| 2019 | 30.31% 18/88 |
21.59% 13/258 |
-1.16% 201/268 |
-10.73% 242/253 |
21.47% 2/266 |
| 2018 | -11.51% 52/79 |
- - |
- - |
- - |
-24.17% 211/241 |
| 2017 | 23.23% 22/69 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 易方达标普生物科技人民币A VS. 建信富时100指数(QDII)人民币A(539003) |